Pharma

Novartis launches new share buyback for up to 10% of its stock

March 13, 2023 05:19 PM AEDT | By Reuters

ZURICH (Reuters) - Novartis has launched a new share buyback programme to purchase up to 10% of the pharma company's own shares over the next three ye...

Brazil's RD posts 47% increase in Q4 adjusted net profit

March 08, 2023 10:56 AM AEDT | By Reuters

SAO PAULO (Reuters) - Brazilian pharmacy chain RD SA, Raia Drogasil, posted on Tuesday a 47% jump year-over-year in fourth-quarter adjusted net profit...

Indonesia court hears class-action suit after children die from tain...

January 17, 2023 07:33 PM AEDT | By Reuters

JAKARTA (Reuters) - Families of Indonesian children who died because of tainted cough syrup demanded restitution as an Indonesian court on Tuesday sta...

U.S. to announce list of drugs for pricing negotiations Sept. 1

January 12, 2023 03:11 AM AEDT | By Reuters

By Ahmed Aboulenein WASHINGTON (Reuters) - The U.S. government will announce a list of 10 prescription drugs for which it plans to negotiate the price...

U.S. extends COVID-19 public health emergency status - CNBC

January 12, 2023 02:42 AM AEDT | By Reuters

(Reuters) -The United States on Wednesday extended the COVID-19 pandemic's status as a public health emergency until April, CNBC reported on Wednesday...

U.S. FDA grants priority review to Roche's bispecific antibody Glofi...

January 06, 2023 05:34 PM AEDT | By Reuters

ZURICH (Reuters) - Roche announced on Friday the U.S. Food and Drug Administration has granted priority review to the Swiss pharmaceutical company's b...

Japan's Meiji Holdings says drug unit started late-stage trial for C...

December 13, 2022 05:47 PM AEDT | By Reuters

TOKYO (Reuters) - Japan's Meiji Holdings Co said on Tuesday its drug subsidiary had started a Phase III trial of an mRNA-based vaccine for COVID-19. M...

Malaria deaths dip in 2021 after rising in first year of COVID, says...

December 08, 2022 10:17 PM AEDT | By Reuters

By Pratik Jain (Reuters) - Malaria-related deaths fell slightly in 2021 after a significant increase in the first year of COVID-19, but remained highe...